Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-06-0767
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prognostic Factors for Estrogen Therapy of Relapsed Prostate Cancer After Maximal Androgen Blockade (Mab)

Japanese Journal of Urology
Urology
2010English

Midlife Metabolic Factors and Prostate Cancer Risk in Later Life

International Journal of Cancer
Cancer ResearchOncology
2017English

Identification of New Genetic Risk Factors for Prostate Cancer

Asian Journal of Andrology
MedicineUrology
2008English

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer

Journal of Oncology Practice
Health PolicyOncology
2018English

Genetic and Hormonal Risk Factors for Prostate Cancer in African American Men

2005English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

The Estrogen Receptor and Its Variants as Risk Factors in Breast Cancer

2001English

Risk of the "Androgen Deprivation Syndrome" in Men Receiving Androgen Deprivation for Prostate Cancer

Archives of Internal Medicine
2006English

Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy